Evidence map›Paper›PMID 29176896›Full record

ArticlePloS one2017

Aging-related limit of exercise efficacy on motor decline.

Jennifer C Arnold, Mark A Cantu, Ella A Kasanga, Vicki A Nejtek, Evan V Papa, Nicoleta Bugnariu, Michael F Salvatore

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jennifer C ArnoldDepartment of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
Mark A CantuInstitute for Healthy Aging and Center for Neuroscience Discovery, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Ella A KasangaInstitute for Healthy Aging and Center for Neuroscience Discovery, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Vicki A NejtekInstitute for Healthy Aging and Center for Alzheimer's and Neurodegenerative Disease Research, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Evan V PapaDepartment of Physical & Occupational Therapy, Idaho State University-Meridian Health Science Center, Meridian, ID, United States of America.
Nicoleta BugnariuSchool of Health Professions, University of North Texas Health Science Center, Fort Worth, Texas, United States of America.
Michael F SalvatoreDepartment of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States of America.
Louisiana State University Health Sciences Center Shreveport · USUniversity of North Texas · USUniversity of North Texas Health Science Center · USIdaho State University · US

Funding

Targeting nigral tyrosine hydroxylase to improve locomotion in agingR01AG040261 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI SALVATORE, MICHAEL F · 2012 to 2015
$1.1M
NIA NIH HHS R01 AG040261
6 · The paper itself

Abstract

Identifying lifestyle strategies and allied neurobiological mechanisms that reduce aging-related motor impairment is imperative, given the accelerating number of retirees and increased life expectancy. A physically active lifestyle prior to old age can reduce risk of debilitating motor decline. However, if exercise is initiated after motor decline has begun in the lifespan, it is unknown if aging itself may impose a limit on exercise efficacy to decelerate further aging-related motor decline. In Brown-Norway/Fischer 344 F1 hybrid (BNF) rats, locomotor activity begins to decrease in middle age (12-18 months). One mechanism of aging-related motor decline may be decreased expression of GDNF family receptor, GFRα-1, which is decreased in substantia nigra (SN) between 12 and 30 months old. Moderate exercise, beginning at 18 months old, increases nigral GFRα-1 and tyrosine hydroxylase (TH) expression within 2 months. In aged rats, replenishing aging-related loss of GFRα-1 in SN increases TH in SN alone and locomotor activity. A moderate exercise regimen was initiated in sedentary male BNF rats in a longitudinal study to evaluate if exercise could attenuate aging-related motor decline when initiated at two different ages in the latter half of the lifespan (18 or 24 months old). Motor decline was reversed in the 18-, but not 24-month-old, cohort. However, exercise efficacy in the 18-month-old group was reduced as the rats reached 27 months old. GFRα-1 expression was not increased in either cohort. These studies suggest exercise can decelerate motor decline when begun in the latter half of the lifespan, but its efficacy may be limited by age of initiation. Decreased plasticity of GFRα-1 expression following exercise may limit its efficacy to reverse motor decline.

Indexed as

Motor ActivityPhysical Conditioning, AnimalAgingAnimalsBody WeightDopamineGlial Cell Line-Derived Neurotrophic Factor ReceptorsMaleRatsRats, Inbred F344Substantia NigraTyrosine 3-MonooxygenaseDopamineGlial Cell Line-Derived Neurotrophic Factor ReceptorsTyrosine 3-Monooxygenase

Identifiers

PMID29176896
PMCPMC5703560
OpenAlexW2770101482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.